Overview
Ana Ramirez-Argudo practices in Barcelona, Spain. Ms. Ramirez-Argudo is rated as an Advanced expert by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). Her top areas of expertise are Severe Combined Immunodeficiency (SCID), Orotic Aciduria Type 1, Purine Nucleoside Phosphorylase Deficiency, and Cutis Laxa.
Her clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Severe Combined Immunodeficiency (SCID).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Orotic Aciduria Type 1Ms. Ramirez-Argudo isAdvanced. Learn about Orotic Aciduria Type 1.
- Severe Combined Immunodeficiency (SCID)Ms. Ramirez-Argudo isAdvanced. Learn about Severe Combined Immunodeficiency (SCID).
- Experienced
- Adrenoleukodystrophy (ALD)Ms. Ramirez-Argudo isExperienced. Learn about Adrenoleukodystrophy (ALD).
- CHARGE SyndromeMs. Ramirez-Argudo isExperienced. Learn about CHARGE Syndrome.
- Cutis LaxaMs. Ramirez-Argudo isExperienced. Learn about Cutis Laxa.
- Cystic FibrosisMs. Ramirez-Argudo isExperienced. Learn about Cystic Fibrosis.
- Glutaric Acidemia Type 1Ms. Ramirez-Argudo isExperienced. Learn about Glutaric Acidemia Type 1.
- Hemolytic Disease of the NewbornMs. Ramirez-Argudo isExperienced. Learn about Hemolytic Disease of the Newborn.